AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers
Advanced Search

Presentation Information

10:55 AM - 11:05 AM JST(1:55 AM - 2:05 AM UTC)Virology

[O8-02]Antibody-Dependent Enhancement in Dengue Vaccine Evaluations: Key Insights

*Kouichi Morita1,2, Dengue Vaccine Development Group2 (1. Nagasaki University, Dejima Infectious Disease Research Alliance (DIDA) (Japan), 2. Nagasaki University, Vaccine Research and Development Center (VRDC) (Japan))

Login required to view

Login is required to view some content.
Log in

Comment

To browse or post comments, you must log in.Log in

Back to Session information